• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Persistent neutrophil maturation deficits associate with cognitive impairment in individuals with post-acute sequelae of COVID-19

tetano

Editor, Senior Moderator
Front Immunol

. 2026 Nov 2:17:1885356.
doi: 10.3389/fimmu.2026.1885356. eCollection 2026.

Persistent neutrophil maturation deficits associate with cognitive impairment in individuals with post-acute sequelae of COVID-19​


Ioanna Papatheodorou 1 2 , Petra Lázničková 1 3 , Tereza Feglarová 4 , Gabriela Blažková 1 2 , Kateřina Kuglerová 4 , Michal Santocki 1 , Martina Jurásková 1 3 , Filip Kafka 1 2 , Petros Kolovos 5 , Lubomír Vojtišek 6 , Martin Radvan 7 , Patrik Bartys 8 , David Ulčák 6 9 , Irena Rektorová 6 9 , Marcela Hortová Kohoutková 1 3 , Eliška Bartečková 8 , Jan Frič 1 3 4

Affiliations Expand


Abstract​


Introduction: Post-COVID-19 condition, or post-acute sequelae of COVID-19 (PASC), is characterized by persistent cognitive impairments and immune dysregulation. While neutrophils are critical in acute COVID-19, whether their long-term functional dysregulation contributes to PASC, remains unclear. Thus, we investigated the links between immune system changes, symptom severity and cognitive impairment in PASC.


Methods: In this cross-sectional study, we enrolled 40 individuals with self-reported issues with COVID-19 recovery (PASC) and 37 fully recovered (REC) volunteers. Participants were post-infection at either TP1 (from 6 up to 18 months post-infection, 7 PASC, 20 REC) or at TP2 (from 19 up to 36 months post-infection, 33 PASC, 17 REC). We evaluated the Newcastle post-COVID-19 Syndrome Follow Up Screening (NC) scores for symptom severity, and neuropsychological tests for memory, attention, and executive function. Peripheral blood was analyzed using multicolor flow cytometry, ELISA, clustering, and multivariate regression.


Results: PASC participants in both the TP1 cohort and the TP2 cohort, demonstrated increased NC scores and significant changes in neutrophil numbers and subset composition. In the TP1 cohort, the PASC group showed an increased frequency of activated CD16+CD62Llow neutrophils and a reduced frequency of CXCR4+TREM-1+CCR2+ polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). This was accompanied by elevated soluble TNF receptor 1 (sTNFR1) and decreased sTNFR2 and CXCL12. In the TP2 cohort, PMN-MDSC levels were comparable between REC and PASC groups, alongside increased emergency granulopoiesis regulators IL-3 and IL-6. Multivariate regression revealed significant associations between PMN-MDSC signatures, granulopoiesis-related markers, NC scores, and cognitive test scores in either the TP1 or the TP2 cohort. These results represent cross-sectional observations in participants assessed within the respective post-infection intervals, rather than longitudinal evidence of persistence. The results show that dysregulated granulopoiesis and neutrophil maturation are present even at 18 and 36 months in PASC individuals, potentially associating with overall symptom severity and cognitive impairment.


Conclusions: Despite limitations in cohort size, requiring validation of the associations in larger cohorts, our findings may contribute to the further understanding of PASC and future new transitional perspectives for PASC management.

Keywords: PASC; PMN-MDSC; SARS-CoV-2; biomarkers; cognitive decline; immune dysregulation; neutrophils; post-acute COVID sequelae.
 
Back
Top Bottom